Early assessment of circulating tumor DNA after curative-intent resection predicts tumor recurrence in early-stage and locally advanced non-small-cell lung cancer.

循环肿瘤细胞 阶段(地层学) 液体活检 非小细胞肺癌 癌症 生物标志物 原发性肿瘤 放射科 杜瓦卢马布 化疗
作者
Silvia Waldeck,Jan Mitschke,Sebastian Wiesemann,Michael Rassner,Geoffroy Andrieux,Max Deuter,Jurik Mutter,Anne-Marie Lüchtenborg,Daniel Kottmann,Laurin Titze,Christoph Zeisel,Martina Jolic,Ulrike Philipp,Silke Lassmann,Peter Bronsert,Christine Greil,Justyna Rawluk,Heiko Becker,Lisa K. Isbell,Alexandra Müller,Soroush Doostkam,Bernward Passlick,Melanie Börries,Justus Duyster,Julius Wehrle,Florian Scherer,Nikolas von Bubnoff
出处
期刊:Molecular Oncology [Elsevier BV]
标识
DOI:10.1002/1878-0261.13116
摘要

Circulating tumor DNA (ctDNA) has demonstrated great potential as a noninvasive biomarker to assess minimal residual disease (MRD) and profile tumor genotypes in patients with non-small-cell lung cancer (NSCLC). However, little is known about its dynamics during and after tumor resection, or its potential for predicting clinical outcomes. Here, we applied a targeted-capture high-throughput sequencing approach to profile ctDNA at various disease milestones and assessed its predictive value in patients with early-stage and locally advanced NSCLC. We prospectively enrolled 33 consecutive patients with stage IA to IIIB NSCLC undergoing curative-intent tumor resection (median follow-up: 26.2 months). From 21 patients, we serially collected 96 plasma samples before surgery, during surgery, 1-2 weeks postsurgery, and during follow-up. Deep next-generation sequencing using unique molecular identifiers was performed to identify and quantify tumor-specific mutations in ctDNA. Twelve patients (57%) had detectable mutations in ctDNA before tumor resection. Both ctDNA detection rates and ctDNA concentrations were significantly higher in plasma obtained during surgery compared with presurgical specimens (57% versus 19% ctDNA detection rate, and 12.47 versus 6.64 ng·mL-1 , respectively). Four patients (19%) remained ctDNA-positive at 1-2 weeks after surgery, with all of them (100%) experiencing disease progression at later time points. In contrast, only 4 out of 12 ctDNA-negative patients (33%) after surgery experienced relapse during follow-up. Positive ctDNA in early postoperative plasma samples was associated with shorter progression-free survival (P = 0.013) and overall survival (P = 0.004). Our findings suggest that, in early-stage and locally advanced NSCLC, intraoperative plasma sampling results in high ctDNA detection rates and that ctDNA positivity early after resection identifies patients at risk for relapse.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
嘻嘻哈哈的应助被MTH采纳,获得10
1秒前
1秒前
cv完成签到,获得积分20
1秒前
科研大印发布了新的文献求助10
2秒前
terry完成签到,获得积分10
2秒前
TFoCR7完成签到,获得积分10
2秒前
Kelly发布了新的文献求助10
2秒前
3秒前
3秒前
叶瑶完成签到 ,获得积分10
3秒前
4秒前
漫漫完成签到,获得积分20
4秒前
科研通AI6.3的应助被EVE_AElle_Lee采纳,获得10
4秒前
5秒前
舒一一完成签到,获得积分10
5秒前
PatrickL发布了新的文献求助10
5秒前
木支知完成签到,获得积分10
6秒前
格子布完成签到,获得积分20
7秒前
7秒前
徐木木发布了新的文献求助10
7秒前
8秒前
8秒前
8秒前
格子布发布了新的文献求助10
9秒前
chenruonan的应助被本色风情采纳,获得10
9秒前
9秒前
Ava的应助被之之怪采纳,获得50
9秒前
10秒前
10秒前
Ceylon发布了新的文献求助10
10秒前
Echen发布了新的文献求助10
11秒前
PatrickL完成签到,获得积分10
11秒前
科研通AI6.3的应助被单虽然采纳,获得10
11秒前
11秒前
12秒前
超级涵山发布了新的文献求助10
12秒前
古芍昂发布了新的文献求助10
12秒前
可爱的函函的应助被小小迷糊采纳,获得10
13秒前
科研大印完成签到,获得积分10
14秒前
脏脏包发布了新的文献求助10
14秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
Grapes 1000
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8178695
求助须知:如何正确求助?哪些是违规求助? 9569449
关于积分的说明 21804643
捐赠科研通 7773744
什么是DOI,文献DOI怎么找? 3432903
关于科研通互助平台的介绍 2556873
邀请新用户注册赠送积分活动 2478500